相关实验视频

Updated: Jun 11, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

全基因组测序药物敏感性测试与积极的MDR-TB治疗反应有关

L Larsson¹, C Corbett², G Kalmambetova³

¹The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe;, Institute of Infectious Diseases and Tropical Medicine, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

|September 28, 2024

概括

通过全基因组测序 (WGS) 识别的多耐药结核病 (MDR-TB) 治疗方案中至少有四种敏感药物,可显著改善中亚地区的治疗结果. 传统的药物敏感性测试 (DST) 没有显示这种关联.

科学领域:

传染性疾病传染性疾病
微生物学微生物学
基因组学就是基因组学.

背景情况:

多药耐药结核病 (MDR-TB) 治疗历史上涉及长期的,有毒的疗法.
新兴的三药抗结核病疗法需要评估它们对MDR-TB的有效性,特别是在像中亚这样的高负担地区.

研究的目的:

评估药物敏感性测试 (DST) 方法对MDR-TB治疗反应的影响.
确定一个疗法中敏感药物的最小数量是否与吉尔吉斯共和国治疗的积极结果相关.

主要方法:

在吉尔吉斯共和国对227名耐利芬素 (RR) 和MDR-TB患者进行的队列研究.
全基因组测序 (WGS) 和传统的DST被用于识别易受药物.
后勤回归分析评估了治疗方案敏感性 (≥4种药物) 和治疗反应之间的关联.

主要成果:

在基线时,WGS确定了至少四种敏感药物的疗法与积极的治疗反应有关 (aOR 2.10).
传统的DST没有显示敏感药物数量与治疗反应之间的显著关联.
该研究包括227名参与者,其中30.8%是女性,平均年龄为30.4岁.

结论:

全基因组测序 (WGS) 引导的敏感性测试预测了MDR-TB的积极治疗反应.
在治疗方案中确保至少有四种有效的抗结核病药物对于改善MDR-TB治疗成功至关重要.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...